Descriptor English: | Burkitt Lymphoma | ||||||
Descriptor Spanish: |
Linfoma de Burkitt
| ||||||
Descriptor Portuguese: | Linfoma de Burkitt | ||||||
Descriptor French: | Lymphome de Burkitt | ||||||
Entry term(s): |
African Lymphoma Burkitt Cell Leukemia Burkitt Leukemia Burkitt Tumor Burkitt's Leukemia Burkitt's Lymphoma Burkitt's Tumor Burkitts Leukemia Burkitts Lymphoma Burkitts Tumor L3 Lymphocytic Leukemia L3 Lymphocytic Leukemias Leukemia, Burkitt Leukemia, Burkitt Cell Leukemia, Burkitt's Leukemia, L3 Lymphocytic Leukemia, Lymphoblastic, Burkitt-Type Leukemia, Lymphocytic, L3 Lymphocytic Leukemia, L3 Lymphoma, African Lymphoma, Burkitt Lymphoma, Burkitt's Tumor, Burkitt Tumor, Burkitt's |
||||||
Tree number(s): |
C01.925.256.466.313.165 C01.925.928.313.165 C04.557.386.480.150.165 C15.604.515.569.480.150.165 C20.683.515.761.480.150.165 |
||||||
RDF Unique Identifier: | https://id.nlm.nih.gov/mesh/D002051 | ||||||
Scope note: | A form of undifferentiated malignant LYMPHOMA usually found in central Africa, but also reported in other parts of the world. It is commonly manifested as a large osteolytic lesion in the jaw or as an abdominal mass. B-cell antigens are expressed on the immature cells that make up the tumor in virtually all cases of Burkitt lymphoma. The Epstein-Barr virus (HERPESVIRUS 4, HUMAN) has been isolated from Burkitt lymphoma cases in Africa and it is implicated as the causative agent in these cases; however, most non-African cases are EBV-negative. |
||||||
Allowable Qualifiers: |
BL blood CF cerebrospinal fluid CH chemistry CI chemically induced CL classification CN congenital CO complications DG diagnostic imaging DH diet therapy DI diagnosis DT drug therapy EC economics EH ethnology EM embryology EN enzymology EP epidemiology ET etiology GE genetics HI history IM immunology ME metabolism MI microbiology MO mortality NU nursing PA pathology PC prevention & control PP physiopathology PS parasitology PX psychology RH rehabilitation RT radiotherapy SU surgery TH therapy UL ultrastructure UR urine VE veterinary VI virology |
||||||
Public MeSH Note: | 1998; see BURKITT'S LYMPHOMA 1968-1997; for LEUKEMIA, B-CELL, ACUTE & BURKITT LEUKEMIA see LEUKEMIA, B-CELL, ACUTE 1989-2007; for BURKITT TUMOR see BURKITT'S TUMOR 1968-1997; for LYMPHOMA, BURKITT see LYMPHOMA, BURKITT'S 1968-1997 |
||||||
History Note: | 1998 (1968) |
||||||
DeCS ID: | 29351 | ||||||
Unique ID: | D002051 | ||||||
Documents indexed in the Virtual Health Library (VHL): | Click here to access the VHL documents | ||||||
Date Established: | 1968/01/01 | ||||||
Date of Entry: | 1999/01/01 | ||||||
Revision Date: | 2020/02/28 |
-
-
DISEASES
Infections [C01]Infections -
DISEASES
Infections [C01]Infections -
DISEASES
Neoplasms [C04]Neoplasms
|
Burkitt Lymphoma
- Preferred
African Lymphoma
- Narrower
Burkitt Leukemia
- Related but not broader or narrower
Concept UI |
M0003058 |
Scope note | A form of undifferentiated malignant LYMPHOMA usually found in central Africa, but also reported in other parts of the world. It is commonly manifested as a large osteolytic lesion in the jaw or as an abdominal mass. B-cell antigens are expressed on the immature cells that make up the tumor in virtually all cases of Burkitt lymphoma. The Epstein-Barr virus (HERPESVIRUS 4, HUMAN) has been isolated from Burkitt lymphoma cases in Africa and it is implicated as the causative agent in these cases; however, most non-African cases are EBV-negative. |
Preferred term | Burkitt Lymphoma |
Entry term(s) |
Burkitt Tumor Burkitt's Lymphoma Burkitt's Tumor Burkitts Lymphoma Burkitts Tumor Lymphoma, Burkitt Lymphoma, Burkitt's Tumor, Burkitt Tumor, Burkitt's |
Concept UI |
M0483383 |
Preferred term | African Lymphoma |
Entry term(s) |
Lymphoma, African |
Concept UI |
M000646519 |
Preferred term | Burkitt Leukemia |
Entry term(s) |
Burkitt Cell Leukemia Burkitt's Leukemia Burkitts Leukemia L3 Lymphocytic Leukemia L3 Lymphocytic Leukemias Leukemia, Burkitt Leukemia, Burkitt Cell Leukemia, Burkitt's Leukemia, L3 Lymphocytic Leukemia, Lymphoblastic, Burkitt-Type Leukemia, Lymphocytic, L3 Lymphocytic Leukemia, L3 |
We want your feedback on the new DeCS / MeSH website
We invite you to complete a survey that will take no more than 3 minutes.
Go to survey